|
|
||||||||
Division of Animal Sciences, University of Missouri, Columbia 65211
2 Corresponding author: LucyM{at}missouri.edu
| ABSTRACT |
|---|
|
|
|---|
and GnRH were injected 7 and 9 d after each biopsy to synchronize the second (41 ± 1 d postpartum; 40 DIM) and third (60 ± 1 d postpartum; 60 DIM) tissue collections. Total RNA was isolated and used for mRNA analysis by real-time quantitative reverse transcription PCR. Liver had more GHR, IGF-1, and IGFBP-2 mRNA than the reproductive tissues that were tested. Gene expression for GHR, IGF-1, and IGFPB-2 within tissues did not change across the sampling interval (20 to 60 DIM). The only detected change in gene expression across days was for cyclophilin in uterus (increased after 20 DIM). Parity had an effect on gene expression for GHR in corpus luteum. Neither level of milk production nor body condition score affected the amount of GHR, IGF-1, or IGFBP-2 mRNA in the respective tissues. The repeatability of gene expression within a tissue was 0.25 to 0.5 for most genes. In most instances, expression of a single gene within a tissue was correlated with other genes in the same tissue but was not correlated with the same gene in a different tissue. We did not find evidence for major changes in gene expression within reproductive tissues in postpartum cows. Differences between cows (independent of their BCS and milk production) accounted for a major portion of the variation that we observed.
Key Words: growth hormone insulin-like growth factor-1 insulin-like growth factor binding protein-2 reproduction
| INTRODUCTION |
|---|
|
|
|---|
Components of the growth hormone (GH)/IGF system play an important role in the metabolic transition that favors high milk production after calving (Lucy et al., 2001). Hepatic concentrations of growth hormone receptor (GHR) mRNA and protein decline shortly before calving and remain low during the first week of lactation (Radcliff et al., 2003a,b; Wook Kim et al., 2004). The decrease in liver GHR leads to a reduction in plasma IGF-1 concentrations. Circulating GH concentrations increase because of decreased negative feedback elicited by relatively low blood IGF-1 concentrations (Radcliff et al., 2003a,b; Wook Kim et al., 2004). Greater GH and lesser IGF-1 in blood favor a catabolic state that supports high milk production in early postpartum cows (Lucy, 2004).
Components of the GH/IGF system are predominantly found in liver but are also found in reproductive tissues where they serve several roles, including positive effects on steroidogenesis (Lucy, 2000; Hunter et al., 2004; Webb et al., 2004) and embryo development (Wathes et al., 1998; Watson et al., 1999; Izadyar et al., 2000; Thatcher et al., 2003). In the liver, expression of GHR and IGF-1 are affected by nutrition and metabolism (McGuire et al., 1992; Thissen et al., 1994; Roche, 2006), particularly during the periparturient period (Radcliff et al., 2006). It is unclear, however, whether the expression of GH/IGF system genes within the reproductive tract changes during the postpartum period as well. Furthermore, the possibility that metabolic signals act across all tissues in the cow to affect gene expression in a coordinated manner has not been examined. We hypothesized that the expression of components of the GH/IGF system in reproductive tissues undergoes coordinated regulation with that found in liver and responds to nutritional and metabolic signals during early lactation. The objective was to measure the mRNA expression of GHR, IGF-1, and IGF-binding protein 2 (IGFBP-2) in the liver, uterus, dominant follicle (DF) and corpus luteum (CL) within the same cow at 3 times during the early postpartum period and to determine if stage of lactation, parity, amount of milk production or BCS influenced gene expression. The extent to which gene expression across different tissues was correlated and the repeatability of gene expression was estimated.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental Protocol and Biopsies
Experimental Protocol.
Postpartum ovarian follicular development was monitored every 1 to 2 d by transrectal ultrasonography (Aloka 500V ultrasound scanner with a 7.5-MHz probe, Aloka Co. Ltd., Tokyo, Japan) beginning approximately 7 d after calving. An injection of GnRH (100 µg of Cystorelin, Merial Ltd., Iselin, NJ) was administered i.m. to induce ovulation when there was a growing DF (11 mm or greater in diameter). The DF was classified as having ovulated if it was undetectable by ultrasound on the day after the GnRH injection. Nine days after ovulation a first-wave DF and functional CL (arising from the GnRH-induced ovulation) were present on the ovary. Samples of the liver, uterus, DF, and CL were collected (described subsequently).
Seven days after the first sample collection, an injection of PGF2
(25 mg of Lutalyse, Pfizer Inc., New York, NY) was administered i.m. to regress the CL. Two days later, an injection of GnRH was given to cause ovulation of the DF. Ovulation was verified by ultrasound. Nine days after ovulation, a second set of samples was collected (liver, uterus, DF, and CL). The injection sequence was repeated to prepare the cows for a third sample collection that was scheduled to occur at approximately 58 d postpartum. The treatment and sample collection protocol is presented in Table 1
.
|
Follicular Aspirations.
The DF was collected by ultrasound-guided transvaginal follicular aspiration. The area above the first intercoccygeal space was clipped and disinfected with an iodine scrub solution and 70% ethanol. Lidocaine (5 mL, 2% lidocaine hydrochloride solution) was injected into the first intercoccygeal space and time was allowed for the anesthesia to take effect. The vulva and perianal area were cleaned and disinfected with iodine scrub solution.
An Aloka 500V ultrasound scanner equipped with a 7.5-MHz probe was used for the follicle aspiration procedure. The ultrasound probe was enclosed within a custom-made handle. The handle enclosed the probe cord and fixed the head of the probe at a 30° angle relative to the needle guide. The needle guide ended at the base of the probe, just above the probe head.
The probe and handle were lubricated with a sterile water-based lubricant and positioned in the vagina slightly posterior to the cervix. The ovary containing the DF was manipulated toward the ultrasound probe so that the DF could be inspected and measured before aspiration. A 17-gauge double lumen aspiration needle (Cook Australia, Queensland, Australia) was passed through the needle guide of the handle and then through the vagina. Approximately 2 mL of sterile saline was flushed through the primary lumen of the needle to remove debris that could interfere with the aspiration. The aspiration needle was guided through the stroma of the ovary and into the DF. The follicular fluid and cells were retrieved and up to 10 mL of sterile saline was immediately flushed through the follicular cavity to increase the number of recovered granulosa cells.
The follicular cells were immediately pelleted by centrifugation, and the follicular fluid/saline solution was decanted. The cells were frozen in liquid nitrogen and stored at –80°C. The follicular fluid and saline mixture was frozen at –20°C for subsequent analysis of hormones. Tissue from DF was not successfully obtained at each sample collection and multiple DF were present at some sample collections (n = 5 collections with multiple DF). When 2 estrogenic DF were found, both were collected but their data were excluded in the subsequent data analyses. Follicles that had estradiol to progesterone ratios less than or equal to 1.0 (n = 3) were classified as atretic and were also excluded. The numbers of follicles used in the gene expression analyses were 10, 16, and 11 for the first, second, and third sample collections, respectively.
Luteal Biopsies.
A sample of the CL was collected by needle biopsy immediately following the follicular aspiration, while the cow remained anesthetized. The biopsy needle (18-gauge, 48 cm in length with a 20-mm notch, US Biopsy, Franklin, IN) was passed through the needle guide of the ultrasound probe handle and a sample of the CL was collected by transvaginal biopsy. The luteal tissue was placed in a screw-cap microcentrifuge tube and frozen in liquid nitrogen. The samples were stored at –80°C until RNA isolation. Tissue from CL was not successfully obtained at each sample collection. The numbers of CL used in the gene expression analyses were 14, 19, and 18 for the first, second, and third sample collections, respectively.
Liver Biopsies.
Liver samples were collected by needle biopsy as described by Rhoads et al. (2008). The tissue was frozen in liquid nitrogen and stored at –80°C until RNA extraction. Tissue collection was not successful from one cow so the total number of liver tissue samples in these analyses was 62.
Blood Samples.
Blood samples were collected by coccygeal venipuncture on each of the 3 sample collection dates. Samples were collected into an evacuated glass tube containing EDTA (BD Vacutainer; Franklin Lakes, NJ) and placed on ice for transport to the laboratory. Plasma was harvested from the blood samples following centrifugation at 1,500 x g for 15 min, and subsequently frozen at –20°C.
RNA Isolation
Total cellular RNA was isolated from liver and uterine tissues using the TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturers instructions. The RNA from the DF and CL was isolated using a column method (RNAqueous, Ambion, Austin, TX) because of the small size of samples.
The RNA content of each sample was calculated based on absorbance at 260 nm. The quality of the RNA was evaluated by calculating the ratio of absorbance at 260 and 280 nm, followed by gel electrophoresis (0.8% agarose gel in 0.09 M Tris-borate and 0.002 M EDTA buffer with 0.5 µg/mL of ethidium bromide). The RNA was stored at –80°C until reverse transcription (RT) into cDNA with the SuperScript First Strand Synthesis System for RT-PCR (Invitrogen). The cDNA was stored at –20°C.
Real-Time Quantitative RT-PCR
The amount of GHR, IGF-1, IGFBP-2, and cyclophilin mRNA in liver, uterus, DF, and CL were measured by real-time quantitative RT-PCR (Taqman, Applied Biosystems; Foster City, CA). The primer pairs, probes, and amplification efficiencies for each individual assay were reported previously (Rhoads et al., 2008). The GHR mRNA assayed herein is identical to the total GHR (tGHR) assay in Rhoads et al. (2008). The 25-µL reactions were prepared with 100 nM of probe and 500 nM of primer using the Brilliant QPCR Plus Core Reagent Kit (Stratagene, La Jolla, CA). A no-template control and 3 internal control samples (high, medium, and low) were run in triplicate on every 96-well reaction plate. Twenty-five nanograms of sample was run in triplicate in each assay. The PCR reactions were performed and fluorescence was quantified with the ABI PRISM 7700 Sequence Detector (Applied Biosystems). Analyses of amplification plots were performed with the Sequence Detection Software (Applied Biosystems). An internal control sample (cDNA sample from fetal liver that was used in every assay) was included in each RT-PCR plate. This internal control was used as a reference sample for calculating relative changes in mRNA expression within each individual sample. The fold difference between the internal control sample and the individual sample was calculated by using the amplification efficiencies reported in Rhoads et al. (2008). For each respective target gene, the fold difference for the individual sample was equal to the amplification efficiency raised to the power of the internal control cycle threshold (CT) minus the sample CT.
Hormone Assays
Plasma GH (Gorewit, 1981) and IGF-1 (Rhoads et al., 2008) concentrations were measured by validated homologous double antibody RIA. The plasma GH and IGF-1 concentrations were each measured in single assays. The intraassay CV was 6.6% for the GH assay and 8.5% for the IGF-1 assay. Plasma estradiol and plasma progesterone were analyzed by validated RIA (Kirby et al., 1997). Plasma estradiol and progesterone concentrations were measured in single assays with intraassay CV of 13.4 and 9.4%, respectively. Follicular fluid progesterone concentrations were also measured in a single RIA with an intraassay CV of 9.2%. Follicular fluid estradiol concentrations were measured with an estradiol kit (Ultra-sensitive Estradiol, Diagnostic Systems Laboratories Inc., Webster, TX) in a single assay with a CV of 9.8%.
Statistical Analysis
Data were analyzed by using the MIXED procedure of SAS (SAS Institute Inc., Cary, NC). The compound symmetry, unstructured and autoregressive 1 covariance structures were tested and the most appropriate (lowest Akaikes information criterion, Akaikes information criterion with correction, and Bayesian information criterion values) was used for each analysis. Sample collection day was included in the model as the repeated variable and cow nested within parity was included as a random effect. The model used for the analyses of milk production, BCS and BW included the effects of day (in this case, sample collection day), parity (2 or
3), and day by parity. The model used for the analyses of plasma hormones (IGF-1, GH, progesterone, and estradiol) and ovarian structures (diameters of the DF and CL) included the effects of day, parity (2 or
3), day by parity, milk production (kilograms of milk produced on the sample day as a continuous variable), and BCS (BCS on the sample day; continuous variable). The fold difference for gene expression (GHR, IGF-1, IGFBP-2, and cyclophilin expression relative to internal control sample) was analyzed in 2 ways. The first set of analyses (tissue model) included the effect of day, tissue, day by tissue, parity, day by parity, milk production, and BCS. The second set of analyses was performed for data that were sorted by tissue and included the effects of day, parity, day by parity, milk production, and BCS. Results are reported as least squares means ± SEM. Separation of means was conducted with the Tukey procedure of SAS. Repeatability of the dependent variables was calculated as the between cow variance divided by the sum of the between cow variance and the residual variance. The REG procedure of SAS was used for linear regression. Statistical significance was declared at P < 0.05.
| RESULTS |
|---|
|
|
|---|
Plasma IGF-1 and GH.
There was an effect of parity on plasma concentrations of IGF-1 because second-parity cows had greater concentrations of plasma IGF-1 than third or greater parity cows (79.4 ± 4.3 vs. 62.7 ± 4.2 ng/mL; P < 0.05). There was no effect of parity on plasma GH concentrations (2.9 ± 0.1 ng/mL). There was no effect of sample collection day on either plasma IGF-1 or plasma GH.
Ovarian Structures and Hormones.
The diameter of the ovulated DF at the time of GnRH injection was smaller before the first sample collection than before the second sample collection (13.9 ± 0.4 mm and 16.1 ± 0.6 mm, respectively; P < 0.05). The diameter of the DF before the third sample collection (15.6 ± 0.8 mm) was intermediate in size and did not differ from the other sample times. The diameters of the DF that were aspirated for hormone and gene expression analyses did not differ at 20, 40, and 60 DIM (Figure 1
), but there was an effect of parity (P < 0.02) and a linear effect of milk production (P < 0.01) on DF diameter. Second-parity cows had larger DF than third or greater parity cows (18.1 ± 0.7 vs. 15.4 ± 0.7 mm) and the diameter of the DF increased with greater milk production (0.3 ± 0.1 mm per kg of milk produced). Follicular fluid estradiol to progesterone ratios were not affected by parity, day, milk production, or BCS. Relative to 20 DIM, the diameter of the CL and plasma progesterone concentrations were greater (P < 0.001 and P < 0.001, respectively) but plasma estradiol concentrations were less (P < 0.01) at 40 and 60 DIM (Figure 1
). There were no effects of parity, milk production, or BCS on the diameter of the CL or plasma concentrations of estradiol or progesterone.
|
|
Repeatability of Gene Expression.
The repeatability (r) for gene expression was typically positive. Most repeatabilities fell within the range of 0.25 to 0.50 (Table 3
). For all tissues except CL, the greatest repeatability among the tested genes was found for IGF-1. The greatest observed repeatability was for IGF-1 in follicle (r = 0.91). For comparison, the repeatabilities for physical characteristics measured for cows in the trial were 0.78 for milk production and 0.85 for BCS. The repeatabilities for plasma IGF-1, GH, progesterone, and estradiol were 0.58, 0.51, 0.20, and 0.04, respectively.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The trial design included a reproductive management program that enabled appropriately timed tissue collections (Table 1
). A series of GnRH and PGF2
injections were used to enable the collection of a DF and a CL that were on d 10 of the induced estrous cycle (GnRH injection = d 0). All cows responded to the GnRH and PGF2
injections in the appropriate manner at all stages of lactation. We found that by using this approach we could collect a DF that was estrogenic and mature in size (Figure 1
). We were able to collect all cows during the luteal phase and this consistent sampling time was important because gene expression within reproductive tissues increases at estrus (Rhoads et al., 2008). The process did reveal some nuances of ovarian development in postpartum cows. For example, the DF were similar in size at the time of all 3 aspirations but the plasma concentrations of estradiol were greatest at the time of the first collection (20 DIM; Figure 1
). We also observed lower blood progesterone and smaller CL at 20 DIM. The first postpartum DF was used for the first ovulation (20 DIM sample). This DF was smaller at GnRH injection than the DF used for later sample collections. Ovulation of a small DF leads to the development of a small CL (Vasconcelos et al., 1999; Quintans et al., 2004). The smaller CL size and lower blood progesterone concentrations, therefore, were most likely a consequence of the smaller DF that ovulated to create the CL for the first sample collection. Perhaps the lower blood progesterone fed back on the pituitary and hypothalamus to affect LH pulsatility (theoretically greater when progesterone is lower). The change in LH pulsatility may have affected the estrogenic capacity of the follicle and caused elevated plasma estradiol (Figure 1
).
Our original intent was to capture cows that were recoupling their somatotropic axis. The cows on this trial did have greater milk production at the later sample times but BCS and BW indicated that the cows maintained a stable energetic balance throughout the sampling period. In addition, plasma GH and IGF-1 concentrations were similar at all 3 DIM, indicating that by the time the sample collections began, the cows had already recovered from the hepatic GH resistance that occurs during the early postpartum period. This was unfortunate and unexpected but we could not have realistically sampled cows earlier postpartum and achieved the goal of sampling multiple tissues from the same cow.
Our analyses of gene expression demonstrated different levels of expression for IGF system genes in individual tissues. We found little evidence, however, for temporal regulation of their expression (i.e., little change from 20 to 60 DIM). Liver expressed the greatest amount of GHR, IGF-1, and IGFBP-2 mRNA (Table 2
). The differences between liver and other tissues were large. The CL, the tissue with the second-most-abundant amounts for individual transcripts, expressed about one-third the amount of GHR and IGF-1 mRNA when compared with liver. The presence of a relatively large amount of GHR in CL compared with other reproductive tissues agreed with our previous work that demonstrated the presence of GHR mRNA in the large luteal cells (Lucy et al., 1993; Yuan and Lucy, 1996). Growth hormone acting via the GHR may play a role in progesterone synthesis within the CL (Juengel and Niswender, 1999). There was also GHR mRNA in the follicle (granulosa cells) and, in agreement with previous results, the amount of GHR in the bovine follicle was considerably less than what was found in the bovine CL (Lucy et al., 1993; Kirby et al., 1996). We also found a relatively large amount of IGF-1 mRNA in the CL as well as in the DF. The follicular samples that we collected theoretically comprised granulosa cells that came free during the follicular aspiration. The presence of IGF-1 mRNA in the samples that we collected agrees with our previous work showing IGF-1 expression in the granulosa cell layer of the DF (Yuan et al., 1998). We observed relatively low expression (compared with liver) of IGFBP-2 in the DF, a finding that again agrees with our previous work on DF in cattle. We were somewhat surprised to observe extremely low levels of IGFBP-2 in the uterine samples. Very little work has been done in the cow on IGFBP-2 expression in the uterus. Robinson et al. (2000) found relatively low levels of IGFBP-2 expression in the subepithelial stroma but we detected appreciable quantities when the entire uterus was assayed for IGFBP-2 mRNA (Kirby et al., 1996).
The only temporally affected gene was cyclophilin (greatest at 20 DIM in uterus). Cyclophilin is an immunophilin (a class of cytosolic enzymes). The immunophilins are associated with cellular processes such as protein folding, protein tyrosine kinase receptor signaling, and stabilization of calcium release channels (Ivery, 2000). These processes could be upregulated in a tissue that is undergoing active remodeling and regeneration such as the involuting uterus. Other effects that were included in our statistical model were parity, milk production, and BCS. These effects were typically not significant for gene expression in individual tissues. We did observe an effect of parity on GHR in the CL with nearly 2-fold more GHR in the CL of third or greater parity cows. We observed an effect of parity on IGFBP-2 in the uterus as well. We are not aware of any biological reasons for effects of parity on these genes and within these tissues. We did observe an effect of parity on plasma IGF-1 (reduced in older cows), and this observation was associated with a tendency for reduced IGF-1 mRNA in the liver of older cows (P = 0.13). The decrease in IGF-1 in older cows is a consequence of "somatopause," a process through which IGF-1 declines in the blood of older individuals (Rosen, 2000). The decrease in liver IGF-1 mRNA reflects the fact that liver is the primary source of IGF-1 found in the bloodstream (Le Roith et al., 2001).
Tissue from the same cow was sampled multiple times and this sampling scheme enabled the calculation of repeatability, a measurement that can be used to assess the correlation among data collected from the same cow. We found that the repeatability for gene expression was typically in the range of 0.25 to 0.5 (Table 3
) and this level was comparable to the repeatability for plasma GH and IGF-1 for cows from this trial. The greatest repeatabilities were found for IGF-1 in which liver, uterus, and DF had relatively high repeatabilities. The greatest repeatability was for DF IGF-1 (0.91) and this was particularly interesting because the actual follicle was different at each sample collection. Likewise for CL, the repeatabilities for GHR, IGFBP-2, and cyclophilin for CL were all above 0.4 but a different CL was collected at each time. The implications are 2-fold. First, the high repeatability for IGF-1 implies that there are inherent characteristics of the cow that control IGF-1 expression in several different tissues (but apparently not CL, where the repeatability was low). This may relate to the importance of IGF-1 as a growth factor for a variety of biological processes in a wide range of tissues. The second implication is that for ovarian structures (DF and CL), their inherent capacity for gene expression is controlled by factors within the cow that impinge upon individual DF and CL that arise from successive follicular waves and ovulatory events.
We analyzed the correlation of gene expression within and across tissues. The reason for this analysis was to determine if there was coordinated expression of genes in multiple tissues. For example, if a cow were relatively high for IGF-1 gene expression in liver, would she also be high for IGF-1 gene expression in uterus, DF, and (or) CL? Conversely, if a cow were low for liver IGF-1, would other tissues be low as well? The clear answer to this question was that gene expression across tissues was not correlated (neither positively nor negatively). The expression of the genes that we tested in one tissue could not be used to predict gene expression in a second tissue. This observation leads to the conclusion that gene expression is not globally controlled, but rather that the control resides within the individual tissues of the cow. Factors that affect the whole animal can have unique effects at the level of each tissue.
We did, however, find a high correlation for gene expression within tissues (Table 4
). Analyses of gene expression within a tissue involved the analysis of the same RNA sample so some of the correlation can perhaps be explained by the fact that both genes were assayed in the same sample. This argument is tempered somewhat by the fact that not all genes were correlated in every tissue. For example, there was a high correlation between GHR and cyclophilin in follicle but no correlation between GHR and IGF-1 in follicle. The correlated expression of 2 genes within the same tissue sample may simply reflect the overall transcriptional activity of the cells within the tissue sample. Some tissue samples may contain cells with greater overall transcriptional activity and this may manifest itself as greater expression for a variety of genes within the tissue sample. Correlations may also reflect cause and effect. We observed a correlation between GHR and IGF-1 in liver, uterus, and CL. This observation may imply that GH acting through the GHR promotes IGF-1 gene transcription (a well-accepted biological process; Le Roith et al., 2001). We did not see this relationship in follicle where there was no correlation between GHR and IGF-1. The absence of a significant correlation agrees with a study that showed little effect of GH on ovarian IGF-1 expression (Cohick et al., 1996).
An interesting aspect of these analyses is that the linear relationship between 2 genes depended on the tissue from which the RNA was extracted (Table 4
). For example, GHR and cyclophilin are highly correlated and this correlation exists within liver, uterus, DF, follicle, and CL (Table 4
; Figure 2
). Cyclophilin is a classical housekeeping gene and its expression has been used in the past to normalize data in gene expression studies (Rhoads et al., 2003). This use may be acceptable for samples arising from the same tissue. When examining the relationship between GHR and cyclophilin, however, it is clear that the relationship between the 2 genes depends on tissue. In liver, for example, a relatively small change in cyclophilin is associated with a large change in GHR. In uterus, the correlation (r) is equally strong but large changes in uterine cyclophilin are associated with only modest changes in GHR. This may mean that in a tissue such as liver, the factors that control cyclophilin have a large effect on GHR expression but the same is not true for uterus. When the relationship between IGF-1 and cyclophilin is examined (Figure 2B
), the regression for liver and CL are reminiscent (in terms of slope) of the GHR and cyclophilin plot (Figure 2A
). In uterus, however, a more positive relationship is seen and this may reflect greater responsiveness of IGF-1 gene expression to cyclophilin within uterine tissue.
Cause and effect are not established by linear regression. Nonetheless, an interesting relationship was observed between GHR and IGF-1 expression in liver, uterus, and CL. As stated above, GH acting through the GHR causes an increase in cellular IGF-1 expression. This increase in IGF-1 is caused by a signal transducer and activator of transcription (STAT) 5 binding site on the IGF-1 gene (Chia et al., 2006). Activation of STAT5 in response to GH causes an increase in IGF-1 gene transcription. Given this relationship, it makes sense that we observed a correlation between GHR and IGF-1 in liver and CL (Figure 3
). A linear relationship between GHR and IGF-1 was also observed for uterus but the nature of the relationship is distinctly different in as much as small changes in uterine GHR led to large changes in uterine IGF-1. Perhaps this means that the uterine IGF-1 is highly sensitive to GH through the GHR. A small change in GHR in uterus may have major implications for uterine IGF-1 expression. This possibility would explain why dairy cows respond positively in terms of pregnancy rate to recombinant bST treatment (Moreira et al., 2001; Santos et al., 2004; Bilby et al., 2006). It also implies that a small positive change in uterine GHR could greatly increase endometrial IGF-1 production and improve early embryonic development by increasing the concentrations of growth factors in the uterine lumen.
| CONCLUSIONS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Received for publication September 3, 2007. Accepted for publication January 21, 2008.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. S. Okamura, J. F. Bader, D. H. Keisler, and M. C. Lucy Short communication: Growth hormone receptor expression in two dairy breeds during the periparturient period J Dairy Sci, June 1, 2009; 92(6): 2706 - 2710. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |